Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. QNNTF.PINK

Quantum Genomics Société Anonyme (QNNTF PINK) stock market data APIs

$0.1 0(0%) as of July 26, 2024
Price chart is built with Anychart

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.

Quantum Genomics Société Anonyme Financial Data Overview

0.1
0.1
-
0.1
0.1
0.1-3.4
3 762 K
34 764 K
19 796
-0.1363
0.633
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'QNNTF',
Type: 'Common Stock',
Name: 'Quantum Genomics Société Anonyme',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00H1CB0C8',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Quantum Genomics Société Anonyme Fundamental Data is available in our Financial Data APIs

  • Net Revenue 19 796
  • EBITDA -2 873 480
  • Earnings Per Share -0.88
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Quantum Genomics Société Anonyme Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Quantum Genomics Société Anonyme End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Quantum Genomics Société Anonyme latest news via APIs

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placebo The REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new innova...
  • CLINICAL STUDY
  • PARIS STOCK EXCHANGE:ALQGC
  • QUANTUM GENOMICS

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Quantum Genomics Firibastat efficacy non-significant versus placebo The REFRESH study and the development of firibastat in cardiology have been stopped Cash of 11 million euros allotted to the devel...
  • COMPANY SPECIALISING
  • HEART FAILURE
  • QUANTUM GENOMICS CHIEF FINANCIAL OFFICER
  • RESISTANT HYPERTENSION
Do you have any questions?
support@eodhistoricaldata.com